Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial

NCT01692496 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Advanced and / or Metastatic Liposarcoma

Interventions

DRUG: Pazopanib

Sponsor

Grupo Espanol de Investigacion en Sarcomas

Collaborators

[object Object]